Spero Health
-
Services:
- Hepatitis education, counseling, or support
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Individual counseling
- HIV or AIDS education, counseling, or support
- Female
- Male
- Breathalyzer or blood alcohol testing
- STD testing
- TB screening
- Drug and alcohol oral fluid testing
- HIV testing
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Testing for Hepatitis C (HCV)
- Suicide prevention services
- Mental health services
- Social skills development
- Case management service
- Early intervention for HIV
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Matrix Model
- Substance use disorder counseling
- Cognitive behavioral therapy
- Brief intervention
- Motivational interviewing
- Contingency management/motivational incentives
- Telemedicine/telehealth therapy
- Relapse prevention
- Trauma-related counseling
- Anger management
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Outcome follow-up after discharge
- Cash or self-payment
- Medicare
- Medicaid
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Housing services
- Recovery coach
- Assistance with obtaining social services
- Employment counseling or training
- Mentoring/peer support
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- In-network prescribing entity
- Buprenorphine without naloxone
- Medications for Hepatitis C treatment
- Buprenorphine sub-dermal implant
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Clonidine
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Nicotine replacement
- Buprenorphine with naloxone
- Comprehensive mental health assessment
- Screening for tobacco use
- Professional interventionist/educational consultant
- Screening for substance use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for mental disorders
- Smoking permitted in designated area
- Young Adults
- Adults
- Clients with HIV or AIDS
- Clients who have experienced intimate partner violence, domestic violence
- Pregnant/postpartum women
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced trauma
- Clients with co-occurring pain and substance use disorders
- Seniors or older adults
- Clients with co-occurring mental and substance use disorders
- Adult women
- Adult men
- Clients who have experienced sexual abuse
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Substance use treatment
- Vaping permitted in designated area
- Private for-profit organization
Education and Counseling Services
Gender Accepted
Testing
Ancillary Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Opioid Medications used in Treatment
Treatment Approaches
Transitional Services
Payment/Insurance/Funding Accepted
License/Certification/Accreditation
Type of Opioid Treatment
Recovery Support Services
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Pharmacotherapies
Assessment/Pre-treatment
Facility Smoking Policy
Age Groups Accepted
Special Programs/Groups Offered
Type of Care
Facility Vaping Policy
Facility Operation (e.g., Private, Public)